China Evergrande New Energy Vehicle Group Limited (EVGRF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
China Evergrande New Energy Vehicle Group Limited (EVGRF) trades at $0.00 with AI Score 60/100 (Grade B+). China Evergrande New Energy Vehicle Group Limited is an investment holding company focused on health management and new energy vehicles. Market cap: $2.17M, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for EVGRF: EVGRF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates EVGRF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
EVGRF: 3/4 perspectives are bullish. Dominant signal: Seth Klarman bearish.
How is this calculated? →China Evergrande New Energy Vehicle Group Limited (EVGRF) Healthcare & Pipeline Overview
China Evergrande New Energy Vehicle Group Limited stands at the intersection of healthcare and sustainable transportation, offering a diverse portfolio that includes health management services and new energy vehicles, positioning itself as a multifaceted player in both sectors.
What Is the Investment Thesis for EVGRF?
China Evergrande New Energy Vehicle Group Limited presents a unique investment thesis driven by its dual focus on healthcare services and new energy vehicle production. The company's market cap of $2.17M and a P/E ratio of -0.14 indicate current challenges, yet its strategic initiatives in health management and new energy vehicles could unlock significant growth potential. The ongoing global shift towards sustainable practices and healthcare innovation presents a favorable backdrop for the company's expansion. Key value drivers include its diversified service offerings, potential for market share growth in the health management sector, and the increasing demand for new energy vehicles. The company's commitment to research and development in pharmaceuticals and medical technology further enhances its competitive positioning. However, investors should remain cautious of the negative profit margin of -890.5% and the gross margin of -3.8%, which highlight underlying operational challenges that need to be addressed for sustainable growth.
Based on FMP financials and quantitative analysis
EVGRF Key Highlights
- Market cap of $2.17M reflects the company's current valuation amidst operational challenges.
- P/E ratio of -0.14 indicates negative earnings, suggesting potential financial instability.
- Profit margin of -890.5% highlights significant operational losses that need addressing.
- Gross margin of -3.8% indicates challenges in maintaining profitability in its business segments.
- Beta of 1.12 suggests higher volatility compared to the market, reflecting investor sentiment.
Who Are EVGRF's Competitors?
EVGRF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AONC American Oncology Network, Inc. | $10.00 | +0.00% | $292.48M | 50 |
| BHCCF Benchmark Holdings plc | $0.37 | +0.00% | $225.11M | 41 |
| MAYNF Mayne Pharma Group Limited | $1.65 | +0.00% | $134.06M | 43 |
| MFCSF Medical Facilities Corporation | $12.38 | -3.81% | $217.27M | 47 |
| MKLNF M1 Kliniken AG | $11.73 | +0.00% | $214.81M | 42 |
| HWAIF Healwell AI Inc. | $0.53 | -3.52% | $160.75M | 65 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.35M | 63 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are EVGRF's Key Strengths?
- Diverse portfolio combining healthcare and new energy vehicle sectors.
- Established presence in the Chinese healthcare market.
- Strong potential for growth in the new energy vehicle segment.
- Commitment to research and development fostering innovation.
What Are EVGRF's Weaknesses?
- Negative profit margin indicating operational challenges.
- High volatility reflected in beta of 1.12.
- Limited brand recognition outside of China.
- Dependence on the domestic market for most revenue.
What Could Drive EVGRF Stock Higher?
- Expansion of healthcare services to meet rising demand in urban areas.
- Development of new energy vehicles aligning with global sustainability trends.
- Introduction of innovative healthcare technology solutions to enhance service delivery.
- Strategic partnerships with healthcare organizations to broaden market reach.
- Launch of new medical products and services in response to consumer needs.
What Are the Key Risks for EVGRF?
- Financial-distress signal — its Altman Z-Score of -21.41 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory changes impacting healthcare and automotive operations.
- Financial instability reflected in negative profit margins.
- Competition from established players in both healthcare and new energy sectors.
- Economic downturns affecting consumer spending on healthcare services.
What Are the Growth Opportunities for EVGRF?
- Growth opportunity 1: The global health management market is expected to reach $1 trillion by 2027, driven by increasing consumer awareness and demand for personalized healthcare services. China Evergrande's focus on community health management and elderly care positions it to capture a significant share of this expanding market, particularly in urban areas where healthcare access is critical.
- Growth opportunity 2: The new energy vehicle market is projected to grow at a CAGR of 22% through 2027, driven by technological advancements and regulatory support for sustainable transportation. China Evergrande's investments in smart mobility solutions and lithium-ion battery production place it in a favorable position to benefit from this growth, particularly as global demand for electric vehicles continues to rise.
- Growth opportunity 3: The increasing prevalence of chronic diseases in China presents a substantial opportunity for the company's healthcare services. By expanding its offerings in medical cosmetology and anti-aging services, China Evergrande can tap into the growing consumer demand for preventative health measures and wellness solutions, potentially increasing its revenue streams.
- Growth opportunity 4: With the rise of telemedicine and digital health solutions, China Evergrande's software services can play a crucial role in enhancing healthcare delivery. By integrating technology into its health management services, the company can improve patient engagement and outcomes, positioning itself as a leader in innovative healthcare solutions.
- Growth opportunity 5: The company's commitment to research and development in pharmaceuticals and medical equipment production presents opportunities for innovation and market differentiation. By developing proprietary technologies and products, China Evergrande can enhance its competitive advantage and drive revenue growth in both the healthcare and new energy sectors.
What Opportunities Does EVGRF Have?
- Growing demand for health management services in aging populations.
- Expansion potential in the new energy vehicle market.
- Increasing interest in telemedicine and digital health solutions.
- Potential partnerships with government and healthcare organizations.
What Threats Does EVGRF Face?
- Intense competition from established healthcare and automotive companies.
- Regulatory challenges in the healthcare and automotive sectors.
- Economic fluctuations impacting consumer spending on healthcare.
- Technological advancements by competitors could outpace company innovations.
What Are EVGRF's Competitive Advantages?
- Diversified service offerings that cater to both healthcare and sustainable transportation.
- Established brand reputation in the health management sector.
- Strategic investments in research and development for innovative solutions.
- Strong presence in the rapidly growing new energy vehicle market.
- Ability to leverage economies of scale in production and distribution.
What Does EVGRF Do?
Founded in 1999, China Evergrande New Energy Vehicle Group Limited, originally known as Evergrande Health Industry Group Limited, has evolved into a prominent investment holding company headquartered in Guangzhou, China. The company operates primarily in the healthcare sector, focusing on health management services and the development of new energy vehicles. With a commitment to enhancing community health, it provides a range of services, including community health management, medical cosmetology, anti-aging services, elderly care, and rehabilitation. In addition to healthcare services, China Evergrande New Energy Vehicle Group is involved in the wholesale of home care and healthcare products, alongside software services that support healthcare delivery. The company also engages in pharmaceutical research and development, medical equipment production, and the manufacture and sale of smart mobility solutions and lithium-ion batteries. Its strategic pivot to new energy vehicles reflects a growing emphasis on sustainability and innovation in transportation, aligning with global trends towards eco-friendly solutions. This diversification not only broadens its market reach but also positions the company favorably within the rapidly evolving landscape of health management and new energy sectors.
What Products and Services Does EVGRF Offer?
- Develops and sells health and living properties.
- Provides community health management services.
- Offers medical cosmetology and anti-aging services.
- Delivers elderly care and rehabilitation services.
- Wholesale of home care and healthcare products.
- Engages in pharmaceutical research and development.
- Produces medical equipment and smart mobility solutions.
- Manufactures and sells lithium-ion batteries.
How Does EVGRF Make Money?
- Revenue generated through health management services and community health programs.
- Sales from new energy vehicles and related products.
- Wholesale distribution of healthcare products and medical equipment.
- Software services that support healthcare delivery and management.
- Research and development initiatives that lead to innovative healthcare solutions.
What Industry Does EVGRF Operate In?
The healthcare sector, particularly in medical care facilities, is experiencing significant growth driven by an aging population and increasing demand for health management services. The global market for healthcare services is projected to expand as consumers seek comprehensive care solutions. Concurrently, the new energy vehicle market is witnessing rapid advancements, with a projected CAGR of 22% through 2027, driven by technological innovations and government incentives for sustainable transportation. China Evergrande New Energy Vehicle Group Limited is strategically positioned within this competitive landscape, leveraging its dual focus on health management and new energy vehicles to capitalize on emerging market trends.
Who Are EVGRF's Key Customers?
- Individuals seeking health management and wellness services.
- Elderly patients requiring rehabilitation and care.
- Healthcare facilities needing medical equipment and products.
- Consumers interested in new energy vehicles and smart mobility solutions.
- Government and private organizations looking for community health management partnerships.
Company Profile
China Evergrande New Energy Vehicle Group Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Guangzhou, CN. The company is led by CEO Shawn Siu. EVGRF has traded publicly since 2021.
How China Evergrande New Energy Vehicle Group Limited Is Valued
China Evergrande New Energy Vehicle Group Limited carries a market capitalization of $2.17M, placing it in the micro-cap category. Relative to its peer group, EVGRF's quantitative score of 60/100 is above the peer average of 45/100.
ROE 21%Key Financial Metrics
Return on equity for China Evergrande New Energy Vehicle Group Limited stands at 20.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -34.2%, showing how much profit it generates from its asset base. Its free cash flow yield is -90.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.34 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 1/9Financial Health
China Evergrande New Energy Vehicle Group Limited's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -21.41 places it in the distress zone, a signal of elevated financial risk.
EVGRF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's recovery and future potential.
- Community sentiment has shifted positively as discussions around EV market expansion gain traction.
- Strategic partnerships in the EV sector are being formed, indicating growth opportunities ahead.
- Investor interest is rising as the company addresses previous financial challenges, signaling a turnaround.
Bear Case
- Ongoing financial instability raises concerns about the company's ability to sustain operations.
- Negative sentiment persists due to past debt issues and regulatory scrutiny impacting investor confidence.
- Market perception remains cautious as competitors in the EV space continue to outperform.
- Recent news highlights production delays, which could hinder the company's growth trajectory in a rapidly evolving market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
EVGRF Latest News
No recent news available for EVGRF.
EVGRF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EVGRF.
Price Targets
Wall Street price target analysis for EVGRF.
EVGRF MoonshotScore
What does this score mean?
The MoonshotScore rates EVGRF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Shawn Siu
CEO
Shawn Siu has been instrumental in guiding China Evergrande New Energy Vehicle Group Limited through its strategic transformation. With a strong background in business management and operations, he has overseen the company's expansion into new markets and sectors. Siu holds a degree in Business Administration and has extensive experience in the healthcare and automotive industries, which positions him well to lead the company in its dual focus on health management and new energy vehicles.
Track Record: Under Shawn Siu's leadership, the company has diversified its offerings and strengthened its market position. His strategic decisions have led to increased investments in research and development, positioning China Evergrande to capitalize on emerging trends in both healthcare and sustainable transportation.
EVGRF OTC Market Information
The OTC Other tier includes companies that do not meet the listing requirements of major exchanges like NYSE or NASDAQ. These stocks may have lower liquidity and higher volatility, making them riskier investments. Companies in this tier often provide less financial transparency, which can be a concern for investors.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures may result in a lack of transparency.
- Higher volatility and lower liquidity compared to stocks on major exchanges.
- Potential for significant price fluctuations based on market sentiment.
- Regulatory scrutiny may impact operations and stock performance.
- Verify the company's financial health through available reports.
- Assess the management team's experience and track record.
- Evaluate the competitive landscape and market positioning.
- Understand the regulatory environment affecting the business.
- Monitor industry trends that may impact growth prospects.
- Established history since 1999 in the healthcare sector.
- Diverse product offerings across healthcare and automotive sectors.
- Affiliation with China Evergrande Group enhances credibility.
- Engagement in research and development indicates commitment to innovation.
EVGRF Healthcare Stock FAQ
What does China Evergrande New Energy Vehicle Group Limited do?
China Evergrande New Energy Vehicle Group Limited operates as a health management company, providing a range of services including community health management, medical cosmetology, and elderly care. Additionally, the company is involved in the development and sale of new energy vehicles and related technologies, positioning itself at the intersection of healthcare and sustainable transportation.
What do analysts say about EVGRF stock?
Analysts have mixed views on EVGRF stock, primarily due to its negative earnings and operational challenges. Key valuation metrics indicate financial instability, with a P/E ratio of -0.14 and a profit margin of -890.5%. Growth considerations focus on the company's potential in the healthcare and new energy vehicle markets, though caution is advised given its current financial state.
What are the main risks for EVGRF?
Key risks for China Evergrande New Energy Vehicle Group Limited include regulatory challenges that could impact its operations in both healthcare and automotive sectors. Additionally, the company's financial instability, reflected in its negative profit margins, poses a significant risk. Competition from established players in the healthcare and new energy vehicle markets further adds to the uncertainty surrounding the company's growth prospects.
What are the key factors to evaluate for EVGRF?
China Evergrande New Energy Vehicle Group Limited (EVGRF) holds an AI score of 60/100 (moderate). Not financial advice.
How frequently does EVGRF data refresh on this page?
EVGRF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven EVGRF's recent stock price performance?
China Evergrande New Energy Vehicle Group Limited (EVGRF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse portfolio combining healthcare and new energy vehicle sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider EVGRF overvalued or undervalued right now?
Valuing China Evergrande New Energy Vehicle Group Limited (EVGRF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying EVGRF?
Before investing in China Evergrande New Energy Vehicle Group Limited (EVGRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the latest available information; operational challenges may impact future performance.